Eileen S. Walsh

1.8k total citations
20 papers, 844 citations indexed

About

Eileen S. Walsh is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, Eileen S. Walsh has authored 20 papers receiving a total of 844 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 8 papers in Oncology and 5 papers in Cell Biology. Recurrent topics in Eileen S. Walsh's work include Cancer-related Molecular Pathways (5 papers), Microtubule and mitosis dynamics (4 papers) and Protein Kinase Regulation and GTPase Signaling (4 papers). Eileen S. Walsh is often cited by papers focused on Cancer-related Molecular Pathways (5 papers), Microtubule and mitosis dynamics (4 papers) and Protein Kinase Regulation and GTPase Signaling (4 papers). Eileen S. Walsh collaborates with scholars based in United States and Switzerland. Eileen S. Walsh's co-authors include Kenneth D. Tew, Sulabha Ranganathan, Carolyn A. Buser, Kelly Hamilton, Andrew K. Godwin, Paul J. Ciaccio, Nancy E. Kohl, Hans E. Huber, Paul J. Coleman and George D. Hartman and has published in prestigious journals such as Journal of Biological Chemistry, Blood and PLoS ONE.

In The Last Decade

Eileen S. Walsh

20 papers receiving 827 citations

Peers

Eileen S. Walsh
Claudio Zambaldo United States
Monique van Scherpenzeel Netherlands
Ray M. Lee United States
Tatsushi Osawa Japan
Akira Makita Japan
Aneta Szymańska Poland
Prahlad V. Raninga Australia
Yutaro Azuma Japan
Dennis M. DiSorbo United States
Noboru Nakai Japan
Claudio Zambaldo United States
Eileen S. Walsh
Citations per year, relative to Eileen S. Walsh Eileen S. Walsh (= 1×) peers Claudio Zambaldo

Countries citing papers authored by Eileen S. Walsh

Since Specialization
Citations

This map shows the geographic impact of Eileen S. Walsh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eileen S. Walsh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eileen S. Walsh more than expected).

Fields of papers citing papers by Eileen S. Walsh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eileen S. Walsh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eileen S. Walsh. The network helps show where Eileen S. Walsh may publish in the future.

Co-authorship network of co-authors of Eileen S. Walsh

This figure shows the co-authorship network connecting the top 25 collaborators of Eileen S. Walsh. A scholar is included among the top collaborators of Eileen S. Walsh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eileen S. Walsh. Eileen S. Walsh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pillarisetti, Kodandaram, Suzanne C. Edavettal, Mark Mendonça, et al.. (2020). A T-cell–redirecting bispecific G-protein–coupled receptor class 5 member D x CD3 antibody to treat multiple myeloma. Blood. 135(15). 1232–1243. 115 indexed citations
2.
Tomkowicz, Brian, Eileen S. Walsh, Raluca Verona, et al.. (2015). TIM-3 Suppresses Anti-CD3/CD28-Induced TCR Activation and IL-2 Expression through the NFAT Signaling Pathway. PLoS ONE. 10(10). e0140694–e0140694. 57 indexed citations
3.
Barrett, Stephanie E., Marc Abrams, Rob S. Burke, et al.. (2014). An in vivo evaluation of amphiphilic, biodegradable peptide copolymers as siRNA delivery agents. International Journal of Pharmaceutics. 466(1-2). 58–67. 13 indexed citations
4.
Parmar, Rubina, Jonathan Williams, R. M. Garbaccio, et al.. (2014). Novel Endosomolytic Poly(amido amine) Polymer Conjugates for Systemic Delivery of siRNA to Hepatocytes in Rodents and Nonhuman Primates. Bioconjugate Chemistry. 25(5). 896–906. 21 indexed citations
5.
Parmar, Rubina, Eileen S. Walsh, Karen Leander, et al.. (2013). Endosomolytic Bioreducible Poly(amido amine disulfide) Polymer Conjugates for the in Vivo Systemic Delivery of siRNA Therapeutics. Bioconjugate Chemistry. 24(4). 640–647. 33 indexed citations
6.
Dudkin, Vadim, Cheng Wang, Kenneth L. Arrington, et al.. (2012). Pyridyl aminothiazoles as potent Chk1 inhibitors: Optimization of cellular activity. Bioorganic & Medicinal Chemistry Letters. 22(7). 2613–2619. 6 indexed citations
7.
Dudkin, Vadim, Keith Rickert, Constantine Kreatsoulas, et al.. (2012). Pyridyl aminothiazoles as potent inhibitors of Chk1 with slow dissociation rates. Bioorganic & Medicinal Chemistry Letters. 22(7). 2609–2612. 20 indexed citations
8.
Rickert, Keith, Michael D. Schaber, Maricel Torrent, et al.. (2007). Discovery and biochemical characterization of selective ATP competitive inhibitors of the human mitotic kinesin KSP. Archives of Biochemistry and Biophysics. 469(2). 220–231. 40 indexed citations
9.
Roecker, Anthony J., Paul J. Coleman, Swati P. Mercer, et al.. (2007). Kinesin spindle protein (KSP) inhibitors. Part 8: Design and synthesis of 1,4-diaryl-4,5-dihydropyrazoles as potent inhibitors of the mitotic kinesin KSP. Bioorganic & Medicinal Chemistry Letters. 17(20). 5677–5682. 35 indexed citations
10.
11.
Cox, Christopher D., Michael J. Breslin, Paul J. Coleman, et al.. (2005). Kinesin spindle protein (KSP) inhibitors. Part 1: The discovery of 3,5-diaryl-4,5-dihydropyrazoles as potent and selective inhibitors of the mitotic kinesin KSP. Bioorganic & Medicinal Chemistry Letters. 15(8). 2041–2045. 118 indexed citations
12.
DESOLMS, S. J., Suzanne C. MacTough, Anthony W. Shaw, et al.. (2003). Dual Protein Farnesyltransferase−Geranylgeranyltransferase-I Inhibitors as Potential Cancer Chemotherapeutic Agents. Journal of Medicinal Chemistry. 46(14). 2973–2984. 49 indexed citations
13.
Nguyen, Diem N., Craig A. Stump, Eileen S. Walsh, et al.. (2002). Potent inhibitors of farnesyltransferase and geranylgeranyltransferase-I. Bioorganic & Medicinal Chemistry Letters. 12(9). 1269–1273. 18 indexed citations
14.
Buser, Carolyn A., Christopher J. Dinsmore, Christine Fernandes, et al.. (2001). High-Performance Liquid Chromatography/Mass Spectrometry Characterization of Ki4B-Ras in PSN-1 Cells Treated with the Prenyltransferase Inhibitor L-778,123. Analytical Biochemistry. 290(1). 126–137. 24 indexed citations
15.
Trotter, B. Wesley, William C. Lumma, John T. Sisko, et al.. (2001). 2-Arylindole-3-acetamides. Bioorganic & Medicinal Chemistry Letters. 11(7). 865–869. 15 indexed citations
16.
Ranganathan, Sulabha, Paul J. Ciaccio, Eileen S. Walsh, & Kenneth D. Tew. (1999). Genomic sequence of human glyoxalase-I: analysis of promoter activity and its regulation. Gene. 240(1). 149–155. 57 indexed citations
17.
Ciaccio, Paul J., Eileen S. Walsh, & Kenneth D. Tew. (1996). Promoter Analysis of a Human Dihydrodiol Dehydrogenase. Biochemical and Biophysical Research Communications. 228(2). 524–529. 17 indexed citations
18.
Ranganathan, Sulabha, Eileen S. Walsh, & Kenneth D. Tew. (1995). Glyoxalase I in detoxification: studies using a glyoxalase I transfectant cell line. Biochemical Journal. 309(1). 127–131. 43 indexed citations
19.
Ranganathan, Sulabha, Eileen S. Walsh, Andrew K. Godwin, & Kenneth D. Tew. (1993). Cloning and characterization of human colon glyoxalase-I.. Journal of Biological Chemistry. 268(8). 5661–5667. 78 indexed citations
20.
Vanderveer, Lisa, et al.. (1992). Increased levels of glutathione S-transferase π transcript as a mechanism of resistance to ethacrynic acid. Biochemical Journal. 281(1). 219–224. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Claudio Zambaldo Breakdown of academic impact, for papers by Monique van Scherpenzeel Breakdown of academic impact, for papers by Ray M. Lee Breakdown of academic impact, for papers by Tatsushi Osawa Breakdown of academic impact, for papers by Akira Makita Breakdown of academic impact, for papers by Aneta Szymańska Breakdown of academic impact, for papers by Prahlad V. Raninga Breakdown of academic impact, for papers by Yutaro Azuma Breakdown of academic impact, for papers by Dennis M. DiSorbo Breakdown of academic impact, for papers by Noboru Nakai
Rankless by CCL
2026